PBLs of Early Breast Carcinoma Patients with a High Nuclear Grade Tumor Unlike PBLs of Cervical Carcinoma Patients Do Not Show a Decreased TCRξ Expression but Are Functionally Impaired
John D. Nieland(Aalborg University), W. Martin Kast(University of Southern California), Rolf Kiessling(Unknown), K. Loviscek(Loyola University Chicago), Susan G. Fisher(NorthShore University HealthSystem), Kathy S. Albain(Loyola University Chicago), Max Petersson, Koji Kono(Fukushima Medical University), Ronald K. Potkul, Markwin P. Velders(Loyola University Chicago), Anne R. McCall(Loyola University Chicago)
Cited by 21
Related Papers
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
|Nature|1986|2.1k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840